Peptidomics is used in a wide and growing range of applications in academia, biotech, and pharmaceutical industry. Being driven by innovative technologies, this novel field utilises the information from genomic data to describe disease states and molecular mechanisms of drug action by analysing the multitude of peptides in living systems. It is already clear that peptidomics is ideally suited for biomarker discovery.

The precise diagnosis and personalised treatment of disease is the vision that motivates researchers to enter peptidomics. In this book the peptidomics pioneer BioVisionN gives insight into its unique technologies of differential display analysis of peptides and illustrates appropriate bioinformatics- and data mining tools. They also describe some of the most prominent medical applications of this rapidly emerging technology in CNS diseases, cancer, and diabetes. In addition the Health Care Competence Center – HC3, a specialist for innovative health care strategies, highlights the role and future perspectives of peptidomics in drug development as determined in a global primary data evaluation in the pharmaceutical industry.